阴道内CO2激光和微消融射频治疗后尿失禁持续多久?一项为期四年的多组随机临床试验(LARF-arm3)。

IF 1.8 3区 医学 Q3 OBSTETRICS & GYNECOLOGY
Ana Silvia Seki, Ana Maria Homem de Mello Bianchi-Ferraro, Tatiana Carvalho Sousa Bonetti, Eliana Suelotto Machado Fonseca, Marair Gracio Ferreira Sartori, Zsuzsanna Ilona Katalin de Jarmy-Di Bella
{"title":"阴道内CO2激光和微消融射频治疗后尿失禁持续多久?一项为期四年的多组随机临床试验(LARF-arm3)。","authors":"Ana Silvia Seki, Ana Maria Homem de Mello Bianchi-Ferraro, Tatiana Carvalho Sousa Bonetti, Eliana Suelotto Machado Fonseca, Marair Gracio Ferreira Sartori, Zsuzsanna Ilona Katalin de Jarmy-Di Bella","doi":"10.1007/s00192-025-06076-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and hypothesis: </strong>CO<sub>2</sub> laser (LS) and microablative radiofrequency (RF) are outpatient options for stress urinary incontinence (SUI) treatment. The aim of this study was to evaluate the lasting effects of SUI treatment using intravaginal CO<sub>2</sub> LS and microablative RF.</p><p><strong>Methods: </strong>This is a long-term follow-up of a prospective double-blind multi-arm randomized controlled trial, involving women with pure or predominant SUI. Participants received three monthly sessions of LS, RF, or were part of a sham control group (SCT) and were followed up, every 6 months, for 48 months to assess continence rates, defined by the composed outcome: no symptoms, negative stress test, and negative 7-day voiding diary.</p><p><strong>Results: </strong>One hundred and thirty-nine women were eligible and randomized into the three groups. One hundred and fourteen participants concluded the treatment protocol. The women's mean age was 50.4 (± 9.5) years. The results showed that both LS and RF treatments led to a mean duration of urinary continence of 26.7 months and 24.58 months respectively, compared with 8.21 months in the SCT group. No major complications were observed.</p><p><strong>Conclusion: </strong>Although the continence rates declined over the time, more than 50% of women in perimenopause, with mild to moderate SUI, pure or predominant SUI, remained without complaints of SUI for at least 24 months after LS or RF application sessions, with no major complications reported.</p>","PeriodicalId":14355,"journal":{"name":"International Urogynecology Journal","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How Long Does Urinary Continence Last After Treatment with Intravaginal CO<sub>2</sub> Laser and Microablative Radiofrequency? A Four-Year Follow-up of a Multi-arm Randomized Clinical Trial (LARF-arm3).\",\"authors\":\"Ana Silvia Seki, Ana Maria Homem de Mello Bianchi-Ferraro, Tatiana Carvalho Sousa Bonetti, Eliana Suelotto Machado Fonseca, Marair Gracio Ferreira Sartori, Zsuzsanna Ilona Katalin de Jarmy-Di Bella\",\"doi\":\"10.1007/s00192-025-06076-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction and hypothesis: </strong>CO<sub>2</sub> laser (LS) and microablative radiofrequency (RF) are outpatient options for stress urinary incontinence (SUI) treatment. The aim of this study was to evaluate the lasting effects of SUI treatment using intravaginal CO<sub>2</sub> LS and microablative RF.</p><p><strong>Methods: </strong>This is a long-term follow-up of a prospective double-blind multi-arm randomized controlled trial, involving women with pure or predominant SUI. Participants received three monthly sessions of LS, RF, or were part of a sham control group (SCT) and were followed up, every 6 months, for 48 months to assess continence rates, defined by the composed outcome: no symptoms, negative stress test, and negative 7-day voiding diary.</p><p><strong>Results: </strong>One hundred and thirty-nine women were eligible and randomized into the three groups. One hundred and fourteen participants concluded the treatment protocol. The women's mean age was 50.4 (± 9.5) years. The results showed that both LS and RF treatments led to a mean duration of urinary continence of 26.7 months and 24.58 months respectively, compared with 8.21 months in the SCT group. No major complications were observed.</p><p><strong>Conclusion: </strong>Although the continence rates declined over the time, more than 50% of women in perimenopause, with mild to moderate SUI, pure or predominant SUI, remained without complaints of SUI for at least 24 months after LS or RF application sessions, with no major complications reported.</p>\",\"PeriodicalId\":14355,\"journal\":{\"name\":\"International Urogynecology Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-02-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Urogynecology Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00192-025-06076-3\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urogynecology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00192-025-06076-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

介绍和假设:CO2激光(LS)和微消融射频(RF)是门诊治疗压力性尿失禁(SUI)的选择。本研究的目的是评估使用阴道内CO2 LS和微消融射频治疗SUI的持久效果。方法:这是一项前瞻性双盲多臂随机对照试验的长期随访,涉及纯粹或主要SUI的女性。参与者接受三个月的LS、RF治疗,或作为假对照组(SCT)的一部分,每6个月随访一次,持续48个月,以评估失禁率,由组合结果定义:无症状、阴性应激测试和阴性7天排尿日记。结果:139名女性被随机分为三组。114名参与者完成了治疗方案。女性平均年龄50.4(±9.5)岁。结果显示,LS和RF治疗导致尿失禁的平均持续时间分别为26.7个月和24.58个月,而SCT组为8.21个月。无重大并发症。结论:尽管随着时间的推移,失禁率有所下降,但超过50%的围绝经期女性,轻度至中度SUI,纯粹或主要SUI,在LS或RF应用疗程后至少24个月仍无SUI投诉,无主要并发症报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
How Long Does Urinary Continence Last After Treatment with Intravaginal CO2 Laser and Microablative Radiofrequency? A Four-Year Follow-up of a Multi-arm Randomized Clinical Trial (LARF-arm3).

Introduction and hypothesis: CO2 laser (LS) and microablative radiofrequency (RF) are outpatient options for stress urinary incontinence (SUI) treatment. The aim of this study was to evaluate the lasting effects of SUI treatment using intravaginal CO2 LS and microablative RF.

Methods: This is a long-term follow-up of a prospective double-blind multi-arm randomized controlled trial, involving women with pure or predominant SUI. Participants received three monthly sessions of LS, RF, or were part of a sham control group (SCT) and were followed up, every 6 months, for 48 months to assess continence rates, defined by the composed outcome: no symptoms, negative stress test, and negative 7-day voiding diary.

Results: One hundred and thirty-nine women were eligible and randomized into the three groups. One hundred and fourteen participants concluded the treatment protocol. The women's mean age was 50.4 (± 9.5) years. The results showed that both LS and RF treatments led to a mean duration of urinary continence of 26.7 months and 24.58 months respectively, compared with 8.21 months in the SCT group. No major complications were observed.

Conclusion: Although the continence rates declined over the time, more than 50% of women in perimenopause, with mild to moderate SUI, pure or predominant SUI, remained without complaints of SUI for at least 24 months after LS or RF application sessions, with no major complications reported.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.80
自引率
22.20%
发文量
406
审稿时长
3-6 weeks
期刊介绍: The International Urogynecology Journal is the official journal of the International Urogynecological Association (IUGA).The International Urogynecology Journal has evolved in response to a perceived need amongst the clinicians, scientists, and researchers active in the field of urogynecology and pelvic floor disorders. Gynecologists, urologists, physiotherapists, nurses and basic scientists require regular means of communication within this field of pelvic floor dysfunction to express new ideas and research, and to review clinical practice in the diagnosis and treatment of women with disorders of the pelvic floor. This Journal has adopted the peer review process for all original contributions and will maintain high standards with regard to the research published therein. The clinical approach to urogynecology and pelvic floor disorders will be emphasized with each issue containing clinically relevant material that will be immediately applicable for clinical medicine. This publication covers all aspects of the field in an interdisciplinary fashion
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信